Tokyo, Japan --- Teijin Limited announced today that NOMON, Co., Ltd., the newest member of the Teijin Group's healthcare business, has launched a new supplement, NADaltus, which contains nicotinamide mononucleotide (NMN), a precursor to a substance in the body that decreases with aging.

Maintaining the concentration of this substance in the cells can help keep the body in a healthy state. Since this substance exists naturally, though in very small amounts, in breast milk, certain vegetables, etc., it is found in everyone's body. Because this substance is an important element for maintaining a variety of cellular functions, it should be replenished when it decreases.

To ensure that NADaltus meets Teijin's stringent product-quality criteria, all stages of manufacture and control, from raw ingredients to final product, are carried out in Japan.

Teijin Group's healthcare business is enhancing the quality of life worldwide to help people enjoy fulfilling lives from birth to their final days, including through NOMON products that support productive aging, so people can live their lives fully and in their own individual ways.

About the Teijin Group

Teijin (TSE: 3401) is a technology-driven global group offering advanced solutions in the areas of environmental value; safety, security and disaster mitigation; and demographic change and increased health consciousness. Its main fields of operation are high-performance fibers such as aramid, carbon fibers & composites, healthcare, films, resin & plastic processing, polyester fibers, products converting and IT. The group has over 170 companies and around 20,000 employees spread out over 20 countries worldwide. It posted consolidated sales of JPY888.6 billion (USD 8.1 billion) and total assets of JPY 1020.7 billion (USD 9.3 billion) in the fiscal year ending March 31, 2019.